We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

AI is going to change finance work forever. I am training AI now so that I'll be prepared when that change comes.

Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...

NU’s Q3 showed scale turning into a structural advantage, with 127M customers, rising ARPAC and industry-leading efficiency that allows the company to grow without adding operational friction. Revenue ...

Investors can consider allotting a small portion of their investment portfolio to emerging artificial intelligence (AI) platforms.

With a Price to Book ratio of 18.42, which is 1.07x the industry average, Oracle might be considered overvalued in terms of ...

It's been a strange and volatile year on Wall Street. The Republic took a look at how Arizona's publicly traded companies ...

“Elon Musk is now personally worth 7,400,000 BTC,” Burnett wrote, adding, “The fastest way for Elon to hit $1 trillion would be to begin buying BTC in size. And he can continue using that capital as ...

The 1963 Ferrari 250 GTO sits at a strange intersection of racing history, industrial design and high finance, a place where ...

The conglomerate's longtime CEO is leaving successor Greg Abel with a stock portfolio full of great companies with enormous ...

Fastenal’s latest price target update leaves its fair value estimate largely steady at roughly $43.46 per share, even as a slightly higher discount rate nudges the required return up just a bit. With ...